Your SlideShare is downloading. ×
0
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Hyperbilirubinemia
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Hyperbilirubinemia

4,846

Published on

Hyperbilirubinemia didactics at Neonatal Intensive Care Unit …

Hyperbilirubinemia didactics at Neonatal Intensive Care Unit
Source: Nelson's Textbook of Pediatrics 19th edition
Most pictures were taken from Google images

Published in: Health & Medicine, Sports
5 Comments
35 Likes
Statistics
Notes
No Downloads
Views
Total Views
4,846
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
5
Likes
35
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Hyperbilirubinemia is a common and, in most cases, benign problem in neonates. Nonetheless, untreated, severe indirect hyperbilirubinemia is potentially neurotoxic, and conjugated-direct hyperbilirubinemia often signifies a serious hepatic or systemic illness.Jaundiceit may also be due in part to deposition of the pigment after it has been converted in the liver cell microsome by the enzyme uridinediphosphoglucuronic acid (UDP)-glucuronyltransferase to the polar, water-soluble ester glucuronide of bilirubin (direct reacting).
  • The unconjugated form is neurotoxic in infants at certain concentrations and under various conditions. Conjugated bilirubin is not neurotoxic but indicates a potentially serious disorder.
  • usually becomes apparent in a cephalocaudal progression starting on the face and progressing to the abdomen and then feet, as serum levels increase. Dermal pressure may reveal the anatomic progression of jaundice
  • but clinical examination cannot be depended on to estimate blood levels.
  • By pathologic criteria, kernicterus will develop in ⅓ of infants (all gestational ages) with untreated hemolytic disease and bilirubin levels >25–30 mg/dL. bilirubin interferes with oxygen utilization by cerebral tissue, possibly by injuring the cell membrane; antecedent hypoxic injury increases the susceptibility of brain cells to injury.
  • The term bronze baby syndrome refers to a sometimes-noted dark, grayish-brown skin discoloration in infants undergoing phototherapy. Almost all infants observed with this syndrome have had significant elevation of direct-reacting bilirubin and other evidence of obstructive liver disease. The discoloration may be due to photo-induced modification of porphyrins, which are often present during cholestatic jaundice and may last for many months. Despite the bronze baby syndrome, phototherapy can continue if needed.
  • Transcript

    • 1. Jackie Lou C. Acha West Visayas State University College of Medicine Neonatal Intensive Care Unit
    • 2. Hyperbilirubinemia  The state of excessive amount of bile pigment billirubin in the blood visibly manifested as jaundice. Jaundice  Yellowish discoloration of the skin, sclerae, and mucous membranes due to accumulation of bilirubin pigment
    • 3. Hyperbilirubinemia  Unconjugated bilirubin (Normal: 0.2 to 1.4 mg/dL) - indirect bilirubin - nonpolar - lipid soluble (indirect reacting)  Conjugated bilirubin (Normal: 0.1 to 0.4 mg/dL) - direct bilirubin - polar - water soluble (direct reacting)
    • 4. Hyperbilirubinemia  Incidence  Term – 60%  Preterm – 80%
    • 5.  Bilirubin (bile pigment) - end product of hemoglobin metabolism that is excreted in bile. - Neonates 75% - from catabolism of circulating RBC 25% - from ineffective erythropoeisis (bone marrow) - from turnover of heme proteins and free heme (liver)
    • 6. Bilirubin production and metabolism
    • 7. Bilirubin-Albumin conjugate Bilirubin 2UDP-Diglucuronide 2 UDP Bilirubin diglucuronide (excreted) Blood Liver Uptake of bilirubin by hepatocytes (facilitated transport) Conjugation Secretion (active transport – MRP-2/MOAT) UDP-glucuronyl transferase
    • 8. Conjugated bilirubin Urobilinogen Liver Urobilins (colored cmpds) Terminal Ileum & Large Intestines Β-glucuronidases Entero-hepatic circulation Colon
    • 9. Bilirubin Formation  When the heme portion of hemoglobin is metabolized beliverdin is formed  When beliverdin is reduced it becomes bilirubin, which immediately combines with plasma protein and becomes free bilirubin
    • 10.  Free bilirubin is absorbed by the hepatic cells and is then released from the plasma protein by glucuronide to form bilirubin glucuronide or sulfate which forms bilirubin sulfate.
    • 11.  The conjugated bilirubin is excreted in the bile and is transformed by bacterial flora to urobilinogen which is very soluble.  5% of reabsorbed urobilinogen is excreted in the urine by the kidneys and the rest is re excreted in the liver.
    • 12. Hyperbilirubinemia/Jaundice  Physiologic Jaundice  Non-physiologic Jaundice
    • 13. Clinical Assessment of Jaundice
    • 14. Manifested as yellowing of the:  Face ~5 mg/dl  Abdomen ~15mg/dl  Soles ~20 mg/dl Jaundice usually becomes apparent in a cephalocaudal progression.
    • 15.  Bright yellow/ orange= indirect bilirubin in the skin  Greenish/ muddy yellow cast= jaundice of the obstructive type (direct bilirubin)
    • 16. Common causes of Neonatal Jaundice
    • 17. Risk Factors for Neonatal Hyperbilirubinemia J A U N D I C E  Jaundice visible on the 1st day of life  A sibling with neonatal jaundice or anemia  Unrecognized hemolysis (ABO, Rh incompatibility); UDP-glucoronyl transferace deficiency (Crigler-Najjar, Gilbert disease)  Nonoptimal feeding (formula or breast-feeding)  Deficiency of G6PD  Infection, Infant of diabetic mother, Immaturity (prematurity)  Cephalhematoma or bruising, Central hematocrit >65% (polycythemia)  East Asian, Mediterranean, Native American heritage
    • 18. Physiologic Jaundice  a.k.a. ICTERUS NEONATORUM  Transient  Occurs during the 1st week of life (usually on the 2nd and 3rd day)  A result of: 1. increased bilirubin production 2. decreased ability of the liver to clear the bilirubin from plasma
    • 19.  6-7% of full-term infants have indirect bilirubin levels >12.9 mg/dL  <3% have levels >15 mg/dL
    • 20. Physiologic Jaundice I. Increased bilirubin production  Normal bilirubin production in newborn 8-10 mg/kg/day (twice the rate of normal daily production in the adult)  Normal level of indirect-reacting bilirubin in umbilical cord serum= 1-3mg/dL  Rises at a rate of <5mg/dL/24hr  Peak= between 2nd and 4th days at 5-6mg/dL
    • 21. Factors that result to increased bilirubin production 1. Larger circulating red blood cell volume in the newborn 2. Shortened RBC life span (70-90 days vs 120 days in adult) 3. Substantial production from sources other than senescent red cells 4. Increased enterohepatic circulation of bilirubin
    • 22. Physiologic Jaundice II. Decreased clearance of bilirubin from plasma Factors: 1. Deficient Ligandin, a protein responsible from binding bilirubin in the hepatocyte 2. Decreased activity of the conjugating enzyme, UDP-glucuronosyl transferase (<1% of adult activity during the first 10 days of life)
    • 23. Non-physiologic Jaundice A. Overproduction Hyperbilirubinemia  Blood Group Incompatibilities  Maternal-fetal or feto-fetal transfusions  Non Immune Hemolytic Anemias  Structurally Abnormal Red Cells  Extravascular Hemolysis
    • 24. Non-physiologic Jaundice B. Undersecretion Hyperbilirubinemia  Enzymatic Deficiency  Hormonal Suppression (Breastmilk Jaundice)  Inhibition of Conjugation  Hepatic Cell Injury Due to Infections  Substrate Deficiency (hypoglycemia)  Mechanical Obstruction
    • 25. Over Production Bilirubinemia A. Blood Group Incompatibilities -Rh negative mother and Rh positive infant -ABO incompatibilities
    • 26.  Maternal antibodies are developed from the infant’s antigens which results into hemolysis.  Strongly considered if there is presence of jaundice in the first 24 hours of life.
    • 27. B. Maternal-fetal or Feto-fetal Transfusion  Results into increased number of red cells, the degradation of which the infant liver may not be able to handle.
    • 28. C. Non Immune Hemolytic Anemias  G6PD Deficieny G6PD deficiency  dec. NADPH dec GSH dec. protection of RBCs from oxidants  dec. red cell integrity hemolysis  Excess of Vitamin K given IM
    • 29. D. Structurally Abnormal Red Cells  Pyknocytes –RBC are smaller than normal and have irregular borders with spiny projection.  Spherocytic Anemia –Sphere shaped RBC
    • 30. E. Extravascular Hemolysis  Results in infants with extensive petechiae or large hematomas which leads to severe jaundice due to increased hemoglobin catabolism at these sites.
    • 31. Undersecretion of Bilirubin  Majority of infants with undersecretion hyperbilirubinemia become jaundiced on the second or third day of life.
    • 32. A. Enzymatic Deficiency  Deficient Glucuronyl Transferase – no longer considered physiologic if the duration is longer than 2 weeks and bilirubin levels >12mg/dl in FT and 15mg/dl in PT.
    • 33. B. Hormonal Suppression  Pregnandiol (breastmilk Jaundice) - Present in maternal breast milk which suppresses bilirubin conjugation. -Breast feeding may be stopped and restarted in a period of 48 hours.
    • 34. Breastfeeding Jaundice versus Breastmilk Jaundice Parameters Breastfeeding Jaundice Breastmilk Jaundice Onset 3rd-4th day of life Late- start to rise on day 4; may reach 20-30mg/dL on day 14 then decrease slowly, Normal by 4-12 weeks Pathophysiology Decrease milk intake resulting to increase enterohepatic circulation Unknown; probably due to B- glucuronidase in breastmilk which increase enterohepatic circulation; Normall Liver Function Test, (-) Hemolysis Management Fluid and caloric supplementation If breastfeeding is stopped, rapid decrease in bilirubin level in 48 hours, if resumed may rise to 2-4mg/dL but not to previous level
    • 35.  Thyroxine Deficiency -Thyroxine increases the activity of Glucuronyl transferase which promotes conjugation of bilirubin.
    • 36. C. Inhibition of Conjugation  Sulfonamides and Vitamin K –results in competitive conjugation inhibition of bilirubin.  Galactosemia –absent or deficient galactose 1-phosphate uridyl transferase which is needed in glucuronidation of indirect bilirubin.
    • 37. D. Hepatic Cell Injury Due to Infections -Results in the destruction of liver parenchyma thus reducing liver mass available for bilirubin excretion.
    • 38. E. Substrate Deficiency (hypoglycemia)  Glucose is the precursor of glucuronic acid which is involved in bilirubin conjugation.
    • 39. F. Mechanical Obstruction  Biliary Atresia - obstruction of the bile ducts  Idiopathic Neonatal Hepatitis - giant cell transformation, increased extramedullary hematopoiesis, and inflammation
    • 40. Diagnostic Approach to neonatal Jaundice Jaundice Measure total and direct bilirubin Jaundice not physiological Blood types, Rh, Coombs’, hematocrit, RBC morphology, Reticulo cyte count
    • 41. Increased direct bilirubin Intrauterine Infections Toxoplasmosis Rubella CMV Herpes simplex Syphilis Biliary atresia Paucity of intrahepatic bile ducts Giant cell hepatitis Alpha-antitrypsin deficiency Sepsis Bile Plugs Choledochal cyst Cystic fibrosis Galactosemia Tyrosinosis Hypermethioninemia Increased indirect bilirubin Coombs’ test positive •isoimmunization Rh ABO Minor blood group Coombs’ test negative Hematocrit
    • 42. Hematocrit Normal or low Red cell morphology and reticulocyte count Abnormal Specific morphological abnormalities Spherocytosis Elliptocytosis Stomatocytosis Pyknocytosis Non specific abnormalities ABO incompatibility G6PD deficiency Pyruvate kinase deficiency Alpha-thalassemia DIC High Twin-twin transfusion Maternal-fetal transfusion Delayed cord clamping Small for dates Normal Extravascular blood Cephalhematoma, bruising, other hemorrhage Increased Enterohepatic circulation Breast feeding Pyloric stenosis Small or large bowel obstruction Swallowed blood Metabolic-endocrine Congenital glucuronyl transferase deficiency Galactosemia Hypothyroidism Breast milk jaundice Others: Infants of DM mother; inadequate
    • 43. Kernicterus  If untreated, hyperbilirubinemia can result to kernicterus or the deposition of bilirubin in the brain.  Usually occurs if the bilirubin levels are 25mg/dl or higher in term infants  Toxicity starts at 8-12 mg/dl in sick or low birth weights
    • 44. Clinical Features of Kernicterus ACUTE FORM  Phase 1(1st 1–2 days): poor sucking, stupor, hypotonia, seizures  Phase 2 (middle of 1st wk): hypertonia of extensor muscles, opisthotonos, retrocollis, fever  Phase 3 (after the 1st wk): hypertonia (hypotonia in Spitzer)
    • 45. Kernicterus CHRONIC FORM First year: hypotonia, active deep tendon reflexes, obligatory tonic neck reflexes, delayed motor skills After 1st yr: movement disorders (choreoathetosis, ballismus, tremor), up ward gaze, sensorineural hearing loss
    • 46.  Phototherapy - Primary treatment - infant is unclothed and is exposed to 20 watt daylight or blue fluorescent light at 30 inches.
    • 47. Principle  Bilirubin absorbs light maximally in the blue range (420–470 nm).  Phototherapy detoxifies bilirubin by converting it to photoproducts that are less lipophilic than bilirubin and that can then be excreted without further metabolism
    • 48. Reactions in phototherapy 1. Photo-isomerization (reversible) - toxic native unconjugated 4Z, 15Z- bilirubin is converted into an unconjugated configurational isomer 4Z,15E-bilirubin -comprises about 20% of TSB in a baby under phototherapy 2. Structural isomerization (irreversible) -Bilirubin becomes Lumirubin -cleared from the serum much more rapidly
    • 49. Usually continued for 5 days, the time wherein physiologic jaundice subsides. - Baby’s eyes are shielded to avoid retinal degeneration
    • 50. Complications of phototherapy  loose stools  erythematous macular rash  purpuric rash associated with transient porphyrinemia  overheating  dehydration (increased insensible water loss, diarrhea)  bronze baby syndrome
    • 51. Management  Double volume exchange transfusion -160-180 ml/kg - the quickest way of clearing the bilirubin from circulation.
    • 52.  Phenobarbital given to mothers at 30-60 mg/kg/day 2 to 3 wks prior to delivery or to infants at 5 mg/kg/day after birth is effective in reducing neonatal jaundice.
    • 53. Thank You!
    • 54. Go forth and get one forth! 1. True or False The incidence of hyperbilirubinemia is higher in term compared to preterm babies
    • 55. 2. Based on clinical examination, which of the following reflects the highest serum concentration of bilirubin a. Yellowing of the face b. Yellowing of the teeth c. Yellowing of the abdomen d. Yellowing of the soles
    • 56. 3-4 Give at least 2 risk factors for neonatal hyperbilirubinemia Clue: J A U N D I C E
    • 57. 5. What is the level of serum bilirubin in mg/dL that can usually cause kernicterus
    • 58. 6. Primary treatment for hyperbilirubinemia
    • 59. 7. What is the life span of RBCs in newborns?
    • 60. A premature infant developed a grey-brown coloration during phototherapy. The infant had haemolytic jaundice due to Rhesus incompatibility complicated by cholestasis of thick bile fluid. 8. What is this condition called? 9. Should phototherapy be discontinued? Yes/No
    • 61. 10. What is the enzyme that catalyzes the hepatic conjugation of bilirubin to form bilirubin diglucoronide? Bilirubin + 2UDP-Diglucuronide enzyme? Bilirubin Diglucuronide + 2UDP

    ×